Article Information
PubMed
Print ISSN
Online ISSN
History
- Received June 12, 2003
- Accepted August 8, 2003
- Published online October 21, 2003.
Article Versions
- Earlier version (September 15, 2003 - 14:54).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Tim D. Werry,
- Graeme F. Wilkinson and
- Gary B. Willars
- Department of Cell Physiology and Pharmacology, Maurice Shock Medical Sciences Building, University of Leicester, Leicester, United Kingdom (T.D.W., G.B.W.); and Molecular Pharmacology, Enabling Science and Technology, AstraZeneca, Cheshire, United Kingdom (G.F.W.)
- Address correspondence to:
Dr. Gary B. Willars, Department of Cell Physiology and Pharmacology, University of Leicester, University Rd., Leicester LE1 9HN, UK. E-mail: gbw2{at}le.ac.uk
Statistics from Altmetric.com
Article usage
In this issue
Cross Talk between P2Y2 Nucleotide Receptors and CXC Chemokine Receptor 2 Resulting in Enhanced Ca2+ Signaling Involves Enhancement of Phospholipase C Activity and Is Enabled by Incremental Ca2+ Release in Human Embryonic Kidney Cells
